BIOMAT Database Logo BIOMAT Database Logo

Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis. 2015

Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Department of Internal Medicine, Karatsu Red Cross Hospital, Japan.

Spontaneous regression of methotrexate-related lymphoproliferative disorders (MTX-LPDs) occurs in some patients after withdrawal of MTX. However, the mechanisms by which MTX withdrawal contributes to the spontaneous regression of MTX-LPDs have not been fully elucidated. We herein show that spontaneous regression of MTX-LPDs is associated with the development of significant and transient T-cell large granular lymphocyte (T-LGL) lymphocytosis induced by MTX withdrawal. Since T-LGLs show strong cytotoxicity, their expansion may contribute to the spontaneous regression of lymphoma. Therefore, the development of T-LGL lymphocytosis maybe associated with a favorable prognosis in MTX-LPD patients.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008218 Lymphocytosis Excess of normal lymphocytes in the blood or in any effusion. Lymphocytoses
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.
August 2003, The American journal of pathology,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
CD3+, CD4-, CD8- large granular T-cell lymphoproliferative disorder.
July 1991, American journal of hematology,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
[Angioimmunoblastic T-cell lymphoma with large granular lymphocytosis].
February 2011, Zhongguo shi yan xue ye xue za zhi,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Lymphocytosis: T-cell large granular lymphocyte leukemia.
August 2012, Blood,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
T-cell large granular lymphocytosis associated with malignant thymoma.
August 2012, Leukemia research,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Study of the major phenotype of large granular T-cell lymphoproliferative disorder.
November 1992, American journal of clinical pathology,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Granulated T cell lymphocytosis with neutropenia: malignant or benign chronic lymphoproliferative disorder?
August 1985, Blood,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Chronic T cell lymphocytosis with large granular lymphocytes of helper (OKT4) phenotype.
February 1985, Scandinavian journal of haematology,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
September 2019, Best practice & research. Clinical haematology,
Hiroshi Ureshino, and Chiho Kadota, and Kazuya Kurogi, and Masaharu Miyahara, and Shinya Kimura
Large granular lymphocytosis.
October 1998, Haematologica,
Copied contents to your clipboard!